Long Focus Capital Management, LLC Bio N Tech Se Transaction History
Long Focus Capital Management, LLC
- $2.94 Billion
- Q4 2024
A detailed history of Long Focus Capital Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 910,000 shares of BNTX stock, worth $107 Million. This represents 3.52% of its overall portfolio holdings.
Number of Shares
910,000Holding current value
$107 Million% of portfolio
3.52%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$969 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$519 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$506 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$223 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$213 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.6B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...